Tuesday, March 27, 2012

Mixed markets on lower consumer confidence

Dow was up 8, advancers & decliners were about equal & NAZ gained 6.  The Financial Index was off fractionally to 215 (a 10 month high).  The MLP index added a fraction in the 397s & the REIT index rose a fraction in the 253s (new yearly high territory).  Junk bond funds were mixed or higher while Treasuries rebounded after recent selling.  Oil & gold were flattish, but there is talk about releasing oil from the strategic reserves (more supply coming to market will reduce the price of  crude oil & this is an election year).

JPMorgan Chase Capital XVI (AMJ)


stock chart

Treasury yields:

U.S. 3-month

0.076%

U.S. 2-year

0.327%

U.S. 10-year

2.200%

CLK12.NYM...Crude Oil May 12...106.72 ...Down 0.31  (0.3%)

GCH12.CMX...Gold Mar 12........1,686.70 ...Up 1.20  (0.1%)




Get the latest market update below:



Consumer Confidence in U.S. Holds Close to One-Year High

Photo:   Bloomberg

Consumers' confidence in the US economy dropped in Mar amid higher gas prices after confidence rose to the highest level in a year during the previous month.  The Conference Board said that its Consumer Confidence Index fell to 70.2, down from a revised 71.6 in Feb.  Expectations were for  a reading of 70.  Consumer confidence has made a recovery since it fell to an all-time low of 25.3 in Feb 2009.  However the Mar reading is below the 90 reading that indicates a healthy economy & hasn't been near 90 since Dec 2007.  The indexi s important because spending on things from clothing to health care accounts for 70% of the nation's economic activity.

Consumer Confidence in U.S. Holds Close to One-Year High


Pfizer, a Dow stock & the  largest drugmaker, may go beyond the divestiture plans it has already announced. (exploring strategic alternatives for its animal health & nutrition businesses).  CEO Read, at a recent meeting with Goldam Sachs (GS) indicated he may be willing to further split up the company after selling or spinning off those 2 units,  This follows Abbott (ABT), a Dividend Aristocrat, plans to divide into 2 publicly traded companies, with one focused on drug development & the other on products including medical devices, infant formula & generics.  “Ultimately, our decisions will be driven by value creation for the businesses and delivering the greatest after- tax value for our shareholders over time,” according to a PFE spokesman.  Of the $67B in 2011 revenue, $18B fell under “established products” or “emerging markets.”  The animal health & infant nutrition units that Pfizer is currently divesting had $6.3B in sales.  The stock rose 47¢ & has had a nice run after the  initial announcement about selling off units.

Pfizer Rises After Goldman Raises Possibility of Full Breakup

Pfizer, Inc. (PFE)


stock chart


This is another day when not a lot is happening in the markets.  The decline in consumer confidence is expected after the sharp rise in gas prices.  Dow is within whispering distance of its 2 weeks ago & bulls want to take it higher.  But the gains are coming with difficulty which I see as a very tired, overbought market

Dow Industrials


stock chart







Get your favorite symbols' Trend Analysis TODAY!  

No comments: